United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt) - atovaquone oral suspension is indicated for the prevention of pneumocystis jirovecii pneumonia (pcp) in adults and adolescents (aged 13 years and older) who cannot tolerate trimethoprim-sulfamethoxazole (tmp-smx). atovaquone oral suspension is indicated for the acute oral treatment of mild-to-moderate pcp in adults and adolescents (aged 13 years and older) who cannot tolerate tmp-smx. clinical experience with atovaquone for the treatment of pcp has been limited to subjects with mild-to-moderate pcp (alveolar-arterial oxygen diffusion gradient [(a-a)do2 ] ≤45 mm hg). treatment of more severe episodes of pcp with atovaquone has not been studied. the efficacy of atovaquone in subjects who are failing therapy with tmp-smx has also not been studied. atovaquone oral suspension is contraindicated in patients who develop or have a history of hypersensitivity reactions (e.g., angioedema, bronchospasm, throat tightness, urticaria) to atovaquone or any of the components of atovaquone oral suspension. pregnancy category

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - atovaquone, quantity: 250 mg; proguanil hydrochloride, quantity: 100 mg - tablet - excipient ingredients: povidone; microcrystalline cellulose; poloxamer; sodium starch glycollate type a; hyprolose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 8000; iron oxide red; macrogol 400 - promozio (250mg atovaquone/100mg proguanil hydrochloride) is indicated for:,? prophylaxis of plasmodium falciparum malaria in adults.,? treatment of plasmodium falciparum malaria in adults.

Canada - English - Health Canada

teva canada limited - atovaquone; proguanil hydrochloride - tablet - 250mg; 100mg - atovaquone 250mg; proguanil hydrochloride 100mg - antimalarials

Canada - English - Health Canada

mylan pharmaceuticals ulc - atovaquone; proguanil hydrochloride - tablet - 250mg; 100mg - atovaquone 250mg; proguanil hydrochloride 100mg - antimalarials

United States - English - NLM (National Library of Medicine)

glaxosmithkline llc - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt) - atovaquone 750 mg in 5 ml - mepron oral suspension is indicated for the prevention of pneumocystis jirovecii pneumonia (pcp) in adults and adolescents (aged 13 years and older) who cannot tolerate trimethoprim-sulfamethoxazole (tmp-smx). mepron oral suspension is indicated for the acute oral treatment of mild-to-moderate pcp in adults and adolescents (aged 13 years and older) who cannot tolerate tmp-smx. clinical experience with mepron for the treatment of pcp has been limited to subjects with mild-to-moderate pcp (alveolar-arterial oxygen diffusion gradient [(a-a)do2 ] ≤45 mm hg). treatment of more severe episodes of pcp with mepron has not been studied. the efficacy of mepron in subjects who are failing therapy with tmp-smx has also not been studied. mepron oral suspension is contraindicated in patients who develop or have a history of hypersensitivity reactions (e.g., angioedema, bronchospasm, throat tightness, urticaria) to atovaquone or any of the components of mepron. risk summary available data from postmarketing experience with

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - atovaquone ; proguanil hydrochloride - film coated tablet - 250/100 milligram - proguanil, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals europe limited - atovaquone; proguanil hydrochloride - film-coated tablet - 250 mg/100 milligram(s) - biguanides; proguanil, combinations

Canada - English - Health Canada

sanis health inc - atovaquone; proguanil hydrochloride - tablet - 250mg; 100mg - atovaquone 250mg; proguanil hydrochloride 100mg - antimalarials

Canada - English - Health Canada

glenmark pharmaceuticals canada inc. - atovaquone; proguanil hydrochloride - tablet - 250mg; 100mg - atovaquone 250mg; proguanil hydrochloride 100mg - antimalarials

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - atovaquone; proguanil hydrochloride - film-coated tablet - 250/100 milligram(s) - biguanides; proguanil, combinations